Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HemWell MD is a medical technology company that provides a non-surgical, FDA-cleared solution for the treatment of hemorrhoids. The company's core offering is the HemWell procedure, which utilizes a specialized device to deliver a low-level electrical current, triggering a chemical reaction that shrinks hemorrhoidal tissue. This office-based treatment is designed to be painless, requiring no anesthesia, bowel prep, or significant downtime for the patient. HemWell MD focuses on training physicians and providing the necessary equipment to integrate this modality into gastroenterology and proctology practices across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HemWell MD.